|
|
1.
|
Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention. MedStar authors:
- Beyene, Solomon
- Brathwaite, Echo
- Buchanan, Kyle
- Dan, Kazuhiro
- Dheendsa, Aaphtaab
- Gajanana, Deepakraj
- Garcia-Garcia, Hector M
- Hideo-Kajita, Alexandre
- Iantorno, Micaela
- Kolm, Paul
- Meirovich, Yael
- Melaku, Gebremedhin
- Ozaki, Yuichi
- Rogers, Toby
- Torguson, Rebecca
- Waksman, Ron
Year: 2019
Citation: - American Journal of Cardiology. 123(8):1228-1238, 2019 04 15.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Beyene S, Brathwaite E, Buchanan K, Dan K, Dheendsa A, Gajanana D, Garcia-Garcia HM, Hideo-Kajita A, Iantorno M, Kolm P, Meirovich Y, Melaku G, Ozaki Y, Rogers T, Torguson R, Waksman R
|
|
|
2.
|
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis. MedStar authors:
- Lipinski, Michael J
- Torguson, Rebecca
- Waksman, Ron
- Westman, Peter C
Year: 2016
Citation: - Cardiovascular Revascularization Medicine. , 2016 Oct 21
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Lipinski MJ, Torguson R, Waksman R, Westman PC
|
